CHD

Business Context and Reporting Period

Company: Church & Dwight Co., Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 2, 2010 (First Quarter)
Business Overview: The Company operates three reportable segments: Consumer Domestic (household and personal care), Consumer International (primarily personal care), and Specialty Products Division (specialty chemicals). The first quarter of 2010 included 6 additional days compared to the prior year due to the Company's 4-4-5 week fiscal calendar.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 9.2% year-over-year, driven primarily by a 10.2% increase in product volumes and a 2.7% favorable impact from foreign exchange rates. This was partially offset by lower pricing and unfavorable sales mix (-2.5%) and divested product lines (-1.2%).
• Margin Expansion: Gross margin improved by 210 basis points to 45.0%. Improvements were attributed to higher volumes, lower manufacturing costs (including efficiencies from the new York, PA facility), favorable foreign exchange, and reduced costs from the North Brunswick, NJ facility shutdown. These gains were partially offset by higher slotting costs for new product launches.
• Expense Management: Marketing expenses rose 3.9% to $68.9 million, primarily supporting power brands like ARM & HAMMER and OXICLEAN, though as a percentage of sales, it decreased to 10.9%. SG&A expenses increased 8.0% to $84.6 million due to information systems upgrades, R&D costs, and foreign exchange impacts, partially offset by a $1.0 million gain on the sale of the BRILLO and LAMBERT KAY brands.
• Debt Reduction: Total debt decreased by approximately $71.3 million due to mandatory term loan payments and the full repayment of the $30.0 million accounts receivable securitization facility.

Guidance, Outlook, and Risks

• Outlook: Management projects the 2010 annual effective tax rate to be approximately 36%, excluding discrete items. The Company anticipates that cash from operations and borrowing capacity will be sufficient to meet capital expenditures, debt repayments, pension funding, and dividend payments for the foreseeable future.
• Acquisition: The Company entered into a definitive agreement to acquire the Simply Saline brand from Blairex Laboratories, Inc., with sales of approximately $20 million. The transaction is expected to close in the second quarter of 2010 and will be funded from available cash.
• Risks and Contingencies:
  • Regulatory: The FTC has issued a subpoena regarding an investigation into the Company's distribution and sale of condoms in the U.S. The Company believes its practices are compliant.
  • Environmental: An international facility discharged chemicals in 2009; the Company has accrued $3 million for remediation but cannot assure additional costs will not be incurred.
  • Tax Audits: Tax years 2004-2008 are under audit. It is reasonably possible that settlements or statute expirations in the next 12 months could reduce income tax expense by up to $3 million and pretax interest expense by up to $5 million.
  • Product Regulation: Potential FDA labeling changes regarding nonoxynol-9 (N-9) in condoms could impact sales and incur costs for obsolete inventory.

Investor Verification Checklist

• Verify the impact of the 6-day longer fiscal quarter on year-over-year comparisons.
• Confirm the status and expected closing date of the Simply Saline acquisition.
• Monitor the outcome of the FTC investigation regarding condom distribution practices.
• Review the progress of the North Brunswick facility closure and associated cost savings realization.
• Assess the potential financial impact of the ongoing IRS and state tax audits (potential $3M tax and $5M interest benefit).
• Validate the sustainability of gross margin improvements given the offsetting impact of slotting costs for new product launches.